CTCF is well known to cooperate with cohesin in regulating genome architecture,35 and increased expression of BORIS in previously BORIS-negative cancer cells could thus rewire genome architecture by replacing one or two CTCF molecules at some of its target regions. The gene discussed is CTCF; the disease is cancer.